Agenus (AGEN) Gains from Investment Securities (2014 - 2023)
Agenus (AGEN) posted quarterly Gains from Investment Securities of -$158000.0 for Q4 2023, down 217.04% year-over-year from $135000.0 in Q4 2022, and down 2075.0% quarter-over-quarter from $8000.0 in Q2 2023.
Powered by 
Analysis
Agenus (AGEN) Gains from Investment Securities (2014 - 2023) Analysis & Trends
Agenus' Gains from Investment Securities history runs 10 years deep, the most recent figure standing at -$158000.0 for Q4 2023.
- In Q4 2023, Gains from Investment Securities fell 217.04% year-over-year to -$158000.0; the TTM figure through Dec 2023 stood at -$556000.0 (up 31.78% YoY), while the FY2024 annual figure was -$4.0 million, down 611.15% from the prior year.
- Gains from Investment Securities for Q4 2023 stood at -$158000.0, down from $8000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $14.3 million in Q2 2021, with the low at -$4.4 million in Q1 2020.
- The 5-year median for Gains from Investment Securities is -$7000.0 (2022), against an average of $901894.7.
- Peak annual rise in Gains from Investment Securities reached 3722.31% in 2019, while the deepest fall reached 889.44% in 2019.
- Agenus' Gains from Investment Securities stood at $4.6 million in 2019, then slumped by 174.18% to -$3.4 million in 2020, then jumped by 40.25% to -$2.0 million in 2021, then surged by 106.59% to $135000.0 in 2022, then sank by 217.04% to -$158000.0 in 2023.
- Business Quant data shows AGEN's Gains from Investment Securities at -$158000.0 in Q4 2023, $8000.0 in Q2 2023, and -$406000.0 in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Agenus | 339.80 Mn | 339.80 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -158,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | -406,000.00 |
| Dec 31, 2022 | 135,000.00 |
| Sep 30, 2022 | -7,000.00 |
| Jun 30, 2022 | -407,000.00 |
| Mar 31, 2022 | -536,000.00 |
| Dec 31, 2021 | -2.05 Mn |
| Sep 30, 2021 | 275,000.00 |
| Jun 30, 2021 | 14.30 Mn |
| Mar 31, 2021 | -1.04 Mn |
| Dec 31, 2020 | -3.43 Mn |
| Sep 30, 2020 | 2.20 Mn |
| Jun 30, 2020 | 6.84 Mn |
| Mar 31, 2020 | -4.38 Mn |
| Dec 31, 2019 | 4.63 Mn |
| Sep 30, 2019 | -1.78 Mn |
| Jun 30, 2019 | 213,000.00 |
| Mar 31, 2019 | 2.75 Mn |
| Dec 31, 2018 | 121,000.00 |